HDAC AND PI3K ANTAGONISTS COOPERATE TO INHIBIT GROWTH OF MYC-DRIVEN MEDULLOBLASTOMA

被引：0
|
作者：
Liu, Kun-Wei [1 ]
Pei, Yanxin [1 ,2 ]
Wechsler-Reya, Robert [1 ]
机构：
[1] Sanford Burnham Med Res Inst, La Jolla, CA USA
[2] Childrens Natl Med Ctr, Washington, DC 20010 USA
来源：
NEURO-ONCOLOGY | 2015年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MB-13
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [41] Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma
    Eckerdt, Frank
    Bell, Jonathan B.
    Beauchamp, Elspeth M.
    Clymer, Jessica
    Blyth, Gavin T.
    Kosciuczuk, Ewa M.
    Ma, Quanhong
    Chen, David Z.
    Horbinski, Craig
    Goldman, Stewart
    Munshi, Hidayatullah G.
    Hashizume, Rintaro
    Platanias, Leonidas C.
    MOLECULAR CANCER RESEARCH, 2019, 17 (06) : 1305 - 1315
  • [42] DETERMINING THE IMMUNOMODULATORY POTENTIAL OF PI3KΓ IN AGGRESSIVE MEDULLOBLASTOMA AND THE TUMOR MICROENVIRONMENT
    Yazejian, Rita M.
    Moziak, Kirsten
    Perez, Natalia Munoz
    Pensabene, Juliana
    Martin, Allison
    NEURO-ONCOLOGY, 2024, 26
  • [43] ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN ATTENUATES DNA DAMAGE AND IS A THERAPEUTIC TARGET IN MYC-DRIVEN MEDULLOBLASTOMA
    Abdel-Hafiz, Ahmed
    Madhavan, Krishna
    Balakrishnan, Ilango
    Pierce, Angela
    Wang, Dong
    Danis, Etienne
    Serkova, Natalie
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2020, 22 : 411 - 411
  • [44] Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS
    Molinaro, Angela
    Becattini, Barbara
    Mazzoli, Arianna
    Bleve, Augusto
    Radici, Lucia
    Maxvall, Ingela
    Sopasakis, Victoria Rotter
    Molinaro, Antonio
    Backhed, Fredrik
    Solinas, Giovanni
    CELL METABOLISM, 2019, 29 (06) : 1400 - +
  • [45] Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
    Hanaford, Allison R.
    Alt, Jesse
    Rais, Rana
    Wang, Sabrina Z.
    Kaur, Harpreet
    Thorek, Daniel L. J.
    Eberhart, Charles G.
    Slusher, Barbara S.
    Martin, Allison M.
    Raabe, Eric H.
    TRANSLATIONAL ONCOLOGY, 2019, 12 (10): : 1314 - 1322
  • [46] Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma
    Vo, BaoHan T.
    Li, Chunliang
    Morgan, Marc A.
    Theurillat, Ilan
    Finkelstein, David
    Wright, Shaela
    Hyle, Judith
    Smith, Stephanie M. C.
    Fan, Yiping
    Wang, Yong-Dong
    Wu, Gang
    Orr, Brent A.
    Northcott, Paul A.
    Shilatifard, Ali
    Sherr, Charles J.
    Roussel, Martine F.
    CELL REPORTS, 2017, 18 (12): : 2907 - 2917
  • [47] The Role of PI3K in Met Driven Cancer: A Recap
    Hervieu, Alexia
    Kermorgant, Stephanie
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2018, 5
  • [48] High impact of ITGB1 on Pi3K/AKT expression in medulloblastoma
    Zhu, S.
    Cheng, Z.
    Wu, Z.
    Wang, J.
    NEURO-ONCOLOGY, 2022, 24
  • [49] The intersection of the PI3K/mTOR and HIPPO pathways: a potential therapeutic target for medulloblastoma
    Ronecker, Jennifer S.
    Lee, Paul
    Sridhara, Sudeepta
    LaBagnara, Michael
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2016, 76
  • [50] Targeting BRD4 and PI3K signaling pathways for the treatment of medulloblastoma
    Sethi, Bharti
    Kumar, Virender
    Jayasinghe, Thilina D.
    Dong, Yuxiang
    Ronning, Donald R.
    Zhong, Haizhen A.
    Coulter, Donald W.
    Mahato, Ram I.
    JOURNAL OF CONTROLLED RELEASE, 2023, 354 : 80 - 90
12345